Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.
Stupp R, Tosoni A, Bromberg JEC, Hau P, Campone M, Gijtenbeek J, Frenay M, Breimer L, Wiesinger H, Allgeier A, van den Bent MJ, Bogdahn U, van der Graaf W, Yun HJ, Gorlia T, Lacombe D, Brandes AA. Stupp R, et al. Among authors: gijtenbeek j. Ann Oncol. 2011 Sep;22(9):2144-2149. doi: 10.1093/annonc/mdq729. Epub 2011 Feb 14. Ann Oncol. 2011. PMID: 21321091 Free PMC article. Clinical Trial.
Cyclosporine neurotoxicity: a review.
Gijtenbeek JM, van den Bent MJ, Vecht CJ. Gijtenbeek JM, et al. J Neurol. 1999 May;246(5):339-46. doi: 10.1007/s004150050360. J Neurol. 1999. PMID: 10399863 Review.
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.
Dubbink HJ, Taal W, van Marion R, Kros JM, van Heuvel I, Bromberg JE, Zonnenberg BA, Zonnenberg CB, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Smitt PA, Dinjens WN, van den Bent MJ. Dubbink HJ, et al. Among authors: gijtenbeek jm. Neurology. 2009 Nov 24;73(21):1792-5. doi: 10.1212/WNL.0b013e3181c34ace. Neurology. 2009. PMID: 19933982 Clinical Trial.
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.
Gao Y, Weenink B, van den Bent MJ, Erdem-Eraslan L, Kros JM, Sillevis Smitt P, Hoang-Xuan K, Brandes AA, Vos M, Dhermain F, Enting R, Ryan GF, Chinot O, Ben Hassel M, van Linde ME, Mason WP, Gijtenbeek JMM, Balana C, von Deimling A, Gorlia T, Stupp R, Hegi ME, Baumert BG, French PJ. Gao Y, et al. Among authors: gijtenbeek jmm. Eur J Cancer. 2018 May;94:168-178. doi: 10.1016/j.ejca.2018.02.023. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29571083 Clinical Trial.
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
Bleeker L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI, Gijsbers AH, Dubbink HJ, Kros JM, Gijtenbeek JMM, Kurt E, van der Rijt CCD, Swaak-Kragten AT, de Vos FY, van der Weide HL, French PJ, van den Bent MJ, Wesseling P, Bromberg JEC. Bleeker L, et al. Among authors: gijtenbeek jmm. J Neurooncol. 2023 Mar;162(1):225-235. doi: 10.1007/s11060-023-04285-8. Epub 2023 Mar 15. J Neurooncol. 2023. PMID: 36920679 Free PMC article.
[The treatment of brain metastases].
Gijtenbeek JM, van Eck AT, van der Maazen RW, Koetsveld AC, Punt CJ. Gijtenbeek JM, et al. Ned Tijdschr Geneeskd. 2002 Sep 14;146(37):1724-9. Ned Tijdschr Geneeskd. 2002. PMID: 12357872 Review. Dutch.
[Practice guideline 'Brain metastases' (revision)].
Gijtenbeek JM, Ho VK, Heesters MA, Lagerwaard FJ, de Graeff A, Boogerd W. Gijtenbeek JM, et al. Ned Tijdschr Geneeskd. 2011;155(52):A4141. Ned Tijdschr Geneeskd. 2011. PMID: 22217243 Review. Dutch.
38 results